Combinatorial effects of surface plasma-treating and aligning PCL/chitosan nanofibers on the behavior of stem cell-derived cardiomyocytes for cardiac tissue engineering
Source abstract
Abstract
Pluripotent stem cell (PSC)-derived cardiomyocytes offer vast potential in heart failure therapy, yet their immaturity poses challenges. To solve this issue, a multifaceted approach combining exclusive biochemical/topographical cues in the design of substrates mimicking the cardiac extracellular matrix was followed. Firstly, polycaprolactone (PCL)/chitosan nanofibers were electrospun in a random and aligned fashion, thus forming myocardium-like constructs. The scaffolds were then subjected to Ar and N2 dielectric barrier discharge treatments, thus further improving their surface properties. The Ar plasma incorporated oxygen-containing functionalities onto the nanofibers surface with an additional implantation of nitrogen-containing groups upon N2 plasma treatment, which both enhanced fibers’ wettability. No topographical/dimensional damages were detected post-plasma treatments, except for a slight decrease in the surface roughness of the aligned nanofibers, which led to a decrease in their tensile stress. Both plasmas significantly enhanced the adhesion of PSC-derived cardiomyocytes that displayed more circular versus highly elongated body/nucleus morphologies on random versus aligned nanofibers, respectively. Interestingly, the cell alignment was less pronounced on GeltrexTM-coated nanofibers. Furthermore, increased sarcomere distance and organization were observed on aligned plasma-treated nanofibers, suggesting an enhanced cell maturation. Overall, PCL/chitosan nanofibers with aligned orientation and plasma-induced surface chemistry hold promise in cardiac tissue engineering applications.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine · Polymer Nanocomposite Synthesis and Irradiation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Mortality from ischemic heart disease10.1161/CIRCOUTCOMES.118.005375 ↗
2. Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: a review10.1098/rsif.2015.0254 ↗
3. Heart regeneration10.1038/nature10147 ↗
4. Transplantation of human pluripotent stem cell-derived cardiomyocytes for cardiac regenerative therapy10.3389/fcvm.2021.707890 ↗
5. Heart repair with myocytes10.1161/CIRCRESAHA.118.314336 ↗
6. Stem cell therapy for acute myocardial infarction: MSCs and iPscs10.1080/14712598.2023.2245329 ↗
7. A review of protocols for human iPSC culture, cardiac differentiation, subtype-specification, maturation, and direct reprogramming10.1016/j.xpro.2022.101560 ↗
8. Differentiation of cardiomyocytes from human pluripotent stem cells using monolayer culture
9. Global transcriptional profiles of beating clusters derived from human induced pluripotent stem cells and embryonic stem cells are highly similar10.1186/1471-213X-10-98 ↗
10. Functional cardiomyocytes derived from human induced pluripotent stem cells10.1161/CIRCRESAHA.108.192237 ↗
11. Pluripotent stem cell-derived cardiomyocytes as a platform for cell therapy applications: progress and hurdles for clinical translation10.1016/j.ymthe.2018.02.026 ↗
12. Immaturity of human stem-cell-derived cardiomyocytes in culture: fatal flaw or soluble problem?10.1089/scd.2014.0533 ↗
13. Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine10.1038/s41569-019-0331-x ↗
14. A brief review of current maturation methods for human induced pluripotent stem cells-derived cardiomyocytes10.3389/fcell.2020.00178 ↗
15. Cardiomyocyte Maturation: New phase in development10.1161/CIRCRESAHA.119.315862 ↗
16. Evaluation of changes in morphology and function of human induced pluripotent stem cell derived cardiomyocytes (HiPSC-CMs) cultured on an aligned-nanofiber cardiac patch10.1371/journal.pone.0126338 ↗
17. The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells10.1016/j.biomaterials.2012.11.055 ↗
18. Controlling the contractile strength of engineered cardiac muscle by hierarchal tissue architecture10.1016/j.biomaterials.2012.04.043 ↗
19. Electrospun scaffolds and induced pluripotent stem cell-derived cardiomyocytes for cardiac tissue engineering applications10.3390/bioengineering7030105 ↗
20. Cell alignment induced by anisotropic electrospun fibrous scaffolds alone has limited effect on cardiomyocyte maturation10.1016/j.scr.2016.04.014 ↗
21. Anisotropic microfibrous scaffolds enhance the organization and function of cardiomyocytes derived from induced pluripotent stem cells10.1039/C7BM00323D ↗
22. Combinatorial polymer matrices enhance in vitro maturation of human induced pluripotent stem cell-derived cardiomyocytes10.1016/j.biomaterials.2015.07.004 ↗
23. Developing defined substrates for stem cell culture and differentiation10.1098/rstb.2017.0230 ↗
24. Myocardial tissue engineering using electrospun nanofiber composites10.5483/BMBRep.2016.49.1.165 ↗
25. Differentiation of embryonic stem cells to cardiomyocytes on electrospun nanofibrous substrates10.1002/jbm.b.33022 ↗
26. PGS: Gelatin nanofibrous scaffolds with tunable mechanical and structural properties for engineering cardiac tissues10.1016/j.biomaterials.2013.04.045 ↗
27. Antibacterial Performance of PCL-chitosan core-shell scaffolds10.1166/jnn.2018.14378 ↗
28. Chitosan-based composites: Development and perspective in food preservation and biomedical applications10.3390/polym15153150 ↗
29. Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review10.1016/S0142-9612(00)00126-5 ↗
30. Combinatorial effects of coral addition and plasma treatment on the properties of chitosan/polyethylene oxide nanofibers intended for bone tissue engineering10.1016/j.carbpol.2020.117211 ↗
31. Degradable chitosan-collagen composites seeded with cells as tissue engineered heart valves10.1016/j.hlc.2016.05.116 ↗
32. Polypyrrole-chitosan conductive biomaterial synchronizes cardiomyocyte contraction and improves myocardial electrical impulse propagation10.7150/thno.22599 ↗
33. Chitosan/calcium silicate cardiac patch stimulates cardiomyocyte activity and myocardial performance after infarction by synergistic effect of bioactive ions and aligned nanostructure10.1021/acsami.8b17754 ↗
34. 3D printed chitosan/polycaprolactone scaffold for lung tissue engineering: hope to be useful for COVID-19 studies10.1039/D1RA03410C ↗
35. Evaluation of PCL/chitosan electrospun nanofibers for liver tissue engineering10.1080/00914037.2016.1190931 ↗
36. Fabrication and cellular compatibility of aligned chitosan-PCL fibers for nerve tissue regeneration10.1016/j.carbpol.2011.02.008 ↗
37. Synergetic effect of electrospun PCL fiber size, orientation and plasma-modified surface chemistry on stem cell behavior10.1016/j.apsusc.2019.04.109 ↗
38. Chemical characterization of plasma-activated polymeric surfaces via XPS analyses: A review
39. Comparative study between in-plasma and post-plasma chemical processes occurring at the surface of UHMWPE subjected to medium pressure Ar and N2 plasma activation
40. Unraveling exclusive in-plasma initiated oxidation processes occurring at polymeric surfaces upon O2 Admixtures to Medium Pressure Ar and N2 DBD Treatments10.3390/polym15142978 ↗
41. Plasma surface modification of biomedical polymers: Influence on cell-material interaction10.1007/s11090-012-9394-8 ↗
42. Cyto- and bio-compatibility assessment of plasma-treated polyvinylidene fluoride scaffolds for cardiac tissue engineering10.3389/fbioe.2022.1008436 ↗
43. Surfaces for hearts: Establishing the optimum plasma surface engineering methodology on polystyrene for cardiac cell engineering10.1016/j.apsusc.2023.156822 ↗
44. Enhanced human-induced pluripotent stem cell derived cardiomyocyte maturation using a dual microgradient substrate10.1021/acsbiomaterials.6b00426 ↗
45. Polyethylene terephthalate textiles enhance the structural maturation of human induced pluripotent stem cell-derived cardiomyocytes
46. Wide-ranging diameter scale of random and highly aligned PCL fibers electrospun using controlled working parameters10.1016/j.polymer.2018.10.022 ↗
47. Effects of different sterilization methods on the physico-chemical and bioresponsive properties of plasma-treated polycaprolactone films10.1088/1748-605X/aa51d5 ↗
48. The barrier discharge: basic properties and applications to surface treatment10.1016/S0042-207X(02)00765-0 ↗
49. Chemically defined generation of human cardiomyocytes10.1038/nmeth.2999 ↗
50. Liquid marble technology to create cost-effective 3D cardiospheres as a platform for drug testing and disease modelling10.1016/j.mex.2020.101065 ↗
51. The effect of polarity in the electrospinning process on PCL/chitosan nanofibres' structure, properties and efficiency of surface modification10.1016/j.polymer.2017.07.064 ↗
52. The predominant factor influencing cellular behavior on electrospun nanofibrous scaffolds: Wettability or surface morphology?
53. Polycaprolactone/chitosan blend nanofibres electrospun from an acetic acid/formic acid solvent system10.1016/j.carbpol.2012.01.085 ↗
54. Electro-spinning of pure collagen nano-fibres - Just an expensive way to make gelatin?10.1016/j.biomaterials.2008.02.009 ↗
55. Electrospun scaffolds and induced pluripotent stem cell-derived cardiomyocytes for cardiac tissue engineering applications
56. Human cardiomyocyte interaction with electrospun fibrinogen/gelatin nanofibers for myocardial regeneration10.1080/09205063.2013.789958 ↗
57. Collagen fibril architecture, domain organization, and triple-helical conformation govern its proteolysis10.1073/pnas.0710588105 ↗
58. Nanoscale cues regulate the structure and function of macroscopic cardiac tissue constructs10.1073/pnas.0906504107 ↗
59. Electrospun conductive nanofibrous scaffolds for engineering cardiac tissue and 3D bioactuators10.1016/j.actbio.2017.06.036 ↗
60. Functional comparison of beating cardiomyocytes differentiated from umbilical cord-derived mesenchymal/stromal stem cells and human foreskin-derived induced pluripotent stem cells10.1002/jbm.a.36831 ↗
61. Environmentally friendly chitosan-modified polycaprolactone nanofiber/nanonet membrane for controllable oil/water separation10.1021/acsapm.1c00463 ↗
62. Vascularization of LBL structured nanofibrous matrices with endothelial cells for tissue regeneration10.1039/C6RA26931A ↗
63. Random/aligned electrospun PCL fibrous matrices with modified surface textures: Characterization and interactions with dermal fibroblasts and keratinocytes, Colloids and surfaces B10.1016/j.colsurfb.2022.112724 ↗
64. FTIR study of polycaprolactone chain organization at interfaces10.1016/j.jcis.2004.02.001 ↗
65. Surface properties of plasma-activated chitosan foils10.3390/colloids6010006 ↗
66. Effect of glow discharge plasma on surface modification of chitosan film10.1016/j.ijbiomac.2019.07.039 ↗
67. Plasma treatment of polycaprolactone at medium pressure10.1016/j.surfcoat.2011.02.012 ↗
68. Plasma functionalization of polycaprolactone nanofibers changes protein interactions with cells10.1021/acsami.8b14995 ↗
69. Multifaceted polymeric nerve guidance conduits with distinctive double-layered architecture and plasma-induced inner chemistry gradient for the repair of critical-sized defects10.1016/j.bioadv.2022.213183 ↗
70. Comparative study of the surface properties and cytocompatibility of plasma-treated poly-epsilon-caprolactone nanofibers subjected to different sterilization methods10.1166/jbn.2017.2377 ↗
71. Surface plasma treatment of poly(caprolactone) micro, nano, and multiscale fibrous scaffolds for enhanced osteoconductivity10.1089/ten.tea.2013.0569 ↗
72. Comparative study of different nitrogen -containing plasma modifications applied on 3D porous PCL scaffolds and 2D PCL films10.1016/j.apsusc.2020.146067 ↗
73. Surface functionalization oxygen depth profiles, and wetting behavior of PET treated with different nitrogen plasmas10.1021/am100052w ↗
74. Effect of low-temperature plasma on chitosan-coated PEEK polymer characteristics10.1016/j.eurpolymj.2016.02.024 ↗
75. G. Beamson, High Relution XPS of Organic Polymers. The Scienta ESCA 300 Database, ICIplc, (1992).
76. Improved cell adhesion to flat and porous plasma-treated poly-epsilon-caprolactone samples10.1016/j.surfcoat.2013.06.001 ↗
77. Plasma treatment of random and aligned electrospun PCL nanofibers10.5405/jmbe.1072 ↗
78. Plasma treatment of electrospun PCL random nanofiber meshes (NFMs) for biological property improvement10.1002/jbm.a.34398 ↗
79. Surface treatment of PEOT/PBT (55/45) with a dielectric barrier discharge in air, helium, argon and nitrogen at medium pressure10.3390/ma11030391 ↗
80. Surface modification of electrospun polycaprolactone nanofiber meshes by plasma treatment to enhance biological performance10.1002/smll.200801648 ↗
81. Biomaterials in myocardial tissue engineering10.1002/term.1944 ↗
82. Substrate stiffness modulates gene expression and phenotype in neonatal cardiomyocytes in vitro10.1089/ten.tea.2011.0707 ↗
83. Multifactorial approaches to enhance maturation of human iPSC-derived cardiomyocytes10.1016/j.molliq.2023.122668 ↗
84. Stiff matrix induces switch to pure β-cardiac myosin heavy chain expression in human ESC-derived cardiomyocytes10.1007/s00395-016-0587-9 ↗
85. The regulation of tendon stem cell differentiation by the alignment of nanofibers10.1016/j.biomaterials.2009.11.083 ↗
86. High strength and high modulus electrospun nanofibers10.3390/fib2020158 ↗
87. Physical and chemical investigation of polycaprolactone, nanohydroxyapatite and poly (Vinyl Alcohol) nanocomposite scaffolds
88. Evaluation of changes in morphology and function of human induced pluripotent stem cell derived cardiomyocytes (HiPSC-CMs) cultured on an aligned-nanofiber cardiac patch (vol 10, e0126338, 2015)10.1371/journal.pone.0126338 ↗
89. Integrated manufacturing of suspended and aligned nanofibrous scaffold for structural maturation and synchronous contraction of HiPSC-derived cardiomyocytes10.3390/bioengineering10060702 ↗
90. The sarcomeric cytoskeleton: from molecules to motion10.1242/jeb.124941 ↗
91. Overview of the muscle cytoskeleton10.1002/cphy.c160033 ↗
92. Cardiac sarcomere mechanics in health and disease10.1007/s12551-021-00840-7 ↗
93. Cardiomyocyte maturation10.1161/CIRCRESAHA.119.315862 ↗
94. Three-dimensional poly-(epsilon-Caprolactone) nanofibrous scaffolds promote the maturation of human pluripotent stem cells-induced cardiomyocytes
95. Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells10.1089/scd.2012.0490 ↗
96. Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells10.1016/j.yjmcc.2014.04.005 ↗
97. Human engineered heart tissue: Analysis of contractile force10.1016/j.stemcr.2016.04.011 ↗
98. Enhancement of human iPSC-derived cardiomyocyte maturation by chemical conditioning in a 3D environment10.1016/j.yjmcc.2019.10.001 ↗
99. Advanced maturation of human cardiac tissue grown from pluripotent stem cells10.1038/s41586-018-0016-3 ↗
100. Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest10.1073/pnas.1707316114 ↗